Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation

Alka Garg1, Sanjay Garg, Richard Wong She

  • 1National Burn Centre, Middlemore Hospital, Auckland, New Zealand. garga@middlemore.co.nz

Insights

A new stable, extemporaneous oral liquid formulation of oxandrolone was developed. This addresses the lack of suitable dosage forms, especially for pediatric patients requiring weight-based dosing.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Formulation
  • Medicinal Chemistry

Background:

  • Oxandrolone is clinically valuable for muscle wasting conditions like severe burns.
  • Current oxandrolone dosage forms (tablets) are unsuitable for accurate weight-based dosing, particularly in children.
  • Limited guidance exists for extemporaneous oral liquid formulations of oxandrolone.

Purpose of the Study:

  • To develop and validate a stable, extemporaneous oral liquid formulation of oxandrolone.
  • To provide a practical alternative to existing tablet forms for accurate dosing.
  • To ensure the formulation is suitable for hospital and community pharmacy settings.

Main Methods:

  • Oxandrolone suspensions were prepared using New Zealand-available vehicles and ethanol.
  • High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) were used for assay method development.
  • Formulation stability was assessed according to International Conference on Harmonization (ICH) guidelines over 28 days.

Main Results:

  • A stable extemporaneous liquid formulation of oxandrolone was successfully developed.
  • The formulation utilizes crushed oxandrolone tablets dispersed in Simple Syrup BP or Orablend® vehicle.
  • Confirmed stability for 21 days under evaluation.

Conclusions:

  • A validated, stable oxandrolone oral liquid formulation is now available.
  • This formulation offers a practical solution for accurate oxandrolone dosing, especially for pediatric use.
  • The formulation can be readily prepared in pharmacy settings using accessible materials.

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...